Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Germenis, Anastasios E  [Clear All Filters]
Journal Article
Speletas, M., Kioumi A., Loules G., Hytiroglou P., Tsitouridis J., Christakis J., et al. (2008).  Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.. Blood Cells Mol Dis. 40(3), 353-9.
Speletas, M., Argentou N., Germanidis G., Vasiliadis T., Mantzoukis K., Patsiaoura K., et al. (2011).  Foxp3 expression in liver correlates with the degree but not the cause of inflammation.. Mediators Inflamm. 2011, 827565.
Psarros, F., Koutsostathis N., Farmaki E., Speletas M. G., & Germenis A. E. (2014).  Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.. Int Arch Allergy Immunol. 164(4), 326-32.
Speletas, M., Boukas K., Papadopoulou-Alataki E., Tsitsami E., & Germenis A. E. (2009).  Hereditary angioedema in Greek families caused by novel and recurrent mutations.. Hum Immunol. 70(11), 925-9.
Germanidis, G., Argentou N., Hytiroglou P., Vassiliadis T., Patsiaoura K., Germenis A. E., et al. (2013).  Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation.. Front Immunol. 4, 207.
Sevdali, E., Tsitsami E., Tsinti M., Farmaki E., Papadopoulou-Alataki E., Germenis A. E., et al. (2017).   Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies.. J Immunol Res. 2017, 1514294.
Molyvdas, A., Georgopoulou U., Lazaridis N., Hytiroglou P., Dimitriadis A., Foka P., et al. (2018).  The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.. Cytokine. 110, 389-396.
Speletas, M., Argentou N., Karanikas V., Gramoustianou E. S., Mandala E., Braimi M., et al. (2011).  Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses.. Clin Immunol. 139(2), 155-63.
Mamara, A., Germenis A. E., Kompoti M., Palassopoulou M., Mandala E., Banti A., et al. (2015).  TACI expression and signaling in chronic lymphocytic leukemia.. J Immunol Res. 2015, 478753.
Argentou, N., Germanidis G., Hytiroglou P., Apostolou E., Vassiliadis T., Patsiaoura K., et al. (2016).  TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.. Inflamm Res. 65(5), 355-65.
Speletas, M., Mamara A., Papadopoulou-Alataki E., Iordanakis G., Liadaki K., Bardaka F., et al. (2011).  TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.. J Clin Immunol. 31(4), 550-9.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές